A Randomised Trial of Imatinib Alternating With Regorafenib Compared to Imatinib Alone for the First Line Treatment of Advanced Gastrointestinal Stromal Tumour (GIST) (ALT GIST)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.

ClinicalTrials.gov Identifier: NCT02365441

Recruitment Status : Active, not recruiting

First Posted : February 19, 2015

Last Update Posted : July 7, 2023

View this study on the modernized ClinicalTrials.gov

Sponsor:

Collaborators:

European Organisation for Research and Treatment of Cancer - EORTC

Scandinavian Sarcoma Group

Information provided by (Responsible Party):

Australasian Gastro-Intestinal Trials Group

No Study Results Posted on ClinicalTrials.gov for this Study

About Study Results Reporting on ClinicalTrials.gov

Recruitment Status :	Active, not recruiting
Estimated Primary Completion Date :	December 31, 2023
Estimated Study Completion Date :	December 31, 2023

To Top